医药行业:诺和诺德司美格鲁肽注射液新适应症在华申报上市

太平洋证券股份...
14 Feb

市场表现:2025 年2 月13 日,医药板块涨跌幅-0.49%,跑输沪深300 指数0.11pct,涨跌幅居申万31 个子行业第19 名。各医药子行业中,线下药店(+3.73%)、医院(+0.42%)、医药流通(-0.54%)表现居前,医疗研发外包(-1.46%)、疫苗(-1.29%)、医疗设备(-0.96%)表现居后。个股方面,日涨幅榜前3 位分别为华人健康(+10.84%)、双成药业(+...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10